Ana Maria Mihalcea et al., 2023-12-16: In this post Mihalcea presents methylene blue as a neuroprotective anti-aggregation agent and, in her own words, as applicable to anyone with brain fog, which she attributes to C19 bioweapon toxicity and shedding.
This is applicable to anyone who has brainfog, since that symptoms is a sign of accelerated cognitive impairment induced by the toxicity of the C19 bioweapon and its shedding.
Ana Maria Mihalcea et al., 2023-12-16: In this post Mihalcea presents methylene blue as a neuroprotective anti-aggregation agent and, in her own words, as applicable to anyone with brain fog, which she attributes to C19 bioweapon toxicity and shedding. Author's own commentary on published papers; no original data, dose or N. Date from post metadata (2023-12-16). She elsewhere quotes a review abstract listing depressive disorders among models where MB was neuroprotective (quotation, not her own result). Her causal attribution of brain fog to 'C19 bioweapon' toxicity is her own claim and is not supported by the cited papers. Study type: other.
